Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
München Klinik Schwabing · Friedrich-Alexander-Universität Erlangen-Nürnberg · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,587
total citations
- FWCI
- 107.01
- Percentile
- 100%
- References
- 20
Citations per year
Authors
19- JFJohannes F.E. MannCorresponding
München Klinik Schwabing
- RERoland E. Schmieder
Friedrich-Alexander-Universität Erlangen-Nürnberg
- MMMatthew McQueen
Population Health Research Institute, McMaster University
- LDLeanne Dyal
Population Health Research Institute, McMaster University
- HSHelmut Schumacher
Boehringer Ingelheim (Germany)
Topics & keywords
Topics
Keywords
- Ramipril
- Telmisartan
- Medicine
- Renal function
- Creatinine
- Urology
- Proteinuria
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.